4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0001193125-25-240438
Chief Executive Officer sold 4,242 shares at $66.60 ($282,517)
- Chief Executive Officer acquired 8,334 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Kulkarni Samarth · Chief Executive Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-10-13 | Exercise or conversion : show line 1 in the form | +8,334 | 209,338 | D | ||
| 2025-10-14 | Sale : show line 2 in the form | −4,242 | $66.60 | $282,517 | 205,096 | D |
| Open-market sales · 4,242 sh · avg $66.60 · $282,517 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-10-13 | Exercise or conversion : show line 3 in the form Restricted Stock Units | −8,334 | 8,333 | D |
Loading xslF345X05/ownership.xml…